Effects of IL-4 and IL-13 on adenosine receptor expression and responsiveness of the human mast cell line 1

International Immunopharmacology

Volumn 8, Issue 6, 2008, Pages 866-873

  Versluis, Mieke ^a   Postma, Dirkje S ^a   Timens, Wim ^a   Hylkema, Machteld N ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Adenosine; Adenosine receptors; Asthma; Histamine; Mast cells

Indexed keywords

ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; CYTOKINE; HISTAMINE; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 8;

ARTICLE; ASTHMA; CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; HISTAMINE RELEASE; HUMAN; HUMAN CELL; INCUBATION TIME; MAST CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH2 CELL;

ADENOSINE MONOPHOSPHATE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); BRONCHOCONSTRICTION; CELL LINE, TUMOR; HISTAMINE RELEASE; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-8; MAST CELLS; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; THEOPHYLLINE; VASODILATOR AGENTS;

EID: 42649115424     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.02.001     Document Type: Article

References (36)

1. Cushley M.J., Tattersfield A.E., and Holgate S.T. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol 15 2 (1983) 161-165
2. Driver A.G., Kukoly C.A., Ali S., and Mustafa S.J. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 148 1 (1993) 91-97
3. Polosa R. Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease. Eur Respir J 20 2 (2002) 488-496
4. Fredholm B.B., Arslan G., Halldner L., Kull B., Schulte G., Adén U., et al. Adenosine receptor signalling in vitro and in vivo. Drug Dev Res 52 (2001) 274-282
5. Klinger M., Freissmuth M., and Nanoff C. Adenosine receptors: G protein-mediated signalling and the role of accessory proteins. Cell Signal 14 2 (2002) 99-108
6. 2B receptors. Pharmacol Rev 49 4 (1997) 381-402
7. Rees D.A., Scanlon M.F., and Ham J. Adenosine signalling pathways in the pituitary gland: one ligand, multiple receptors. J Endocrinol 177 (2003) 357-364
8. Razin E., Pecht I., and Rivera J. Signal transduction in the activation of mast cells and basophils. Immunol Today 16 8 (1995) 370-373
9. 2b adenosine receptor antagonist, inhibits degranulation of cultured human but not murine mast cells. J Allergy Clin Immunol 107 2 (2001) S281
10. Suzuki H., Takei M., Nakahata T., and Fukamachi H. Inhibitory effect of adenosine on degranulation of human cultured mast cells upon cross-linking of Fc epsilon RI. Biochem Biophys Res Commun 242 3 (1998) 697-702
11. Hughes P.J., Holgate S.T., and Church M.K. Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism. Biochem Pharmacol 33 23 (1984) 3847-3852
12. Peachell P.T., Lichtenstein L.M., and Schleimer R.P. Differential regulation of human basophil and lung mast cell function by adenosine. J Pharmacol Exp Ther 256 2 (1991) 717-726
13. Batra V., Musani A.I., Hastie A.T., Khurana S., Carpenter K.A., Zangrilli J.G., et al. Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts. Clin Exp Allergy 34 3 (2004) 437-444
14. Chomarat P., and Banchereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol 17 1-4 (1998) 1-52
15. Izuhara K., Arima K., and Yasunaga S. IL-4 and IL-13: their pathological roles in allergic diseases and their potential in developing new therapies. Curr Drug Targets Inflamm Allergy 1 3 (2002) 263-269
16. Bischoff S.C., Sellge G., Lorentz A., Sebald W., Raab R., and Manns M.P. IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci U S A 96 14 (1999) 8080-8085
17. Nilsson G., Blom T., Kusche-Gullberg M., Kjellen L., Butterfield J.H., Sundstrom C., et al. Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol 39 5 (1994) 489-498
18. 3 adenosine receptors. Circ Res 92 5 (2003) 485-492
19. Meade C.J., Worrall L., Hayes D., and Protin U. Induction of interleukin 8 release from the HMC-1 mast cell line: synergy between stem cell factor and activators of the adenosine A(2b) receptor. Biochem Pharmacol 64 2 (2002) 317-325
20. Nilsson G., and Nilsson K. Effects of interleukin (IL)-13 on immediate-early response gene expression, phenotype and differentiation of human mast cells. Comparison with IL-4. Eur J Immunol 25 3 (1995) 870-873
21. 2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 96 4 (1995) 1979-1986
22. van den Berge M., Meijer R.J., Kerstjens H.A., de Reus D.M., Koeter G.H., Kauffman H.F., et al. PC(20) adenosine 5′-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine. Am J Respir Crit Care Med 163 7 (2001) 1546-1550
23. van den Berge M., Kerstjens H.A., and Postma D.S. Provocation with adenosine 5′-monophosphate as a marker of inflammation in asthma, allergic rhinitis and chronic obstructive pulmonary disease. Clin Exp Allergy 32 6 (2002) 824-830
24. Spicuzza L., Di Maria G., and Polosa R. Adenosine in the airways: implications and applications. Eur J Pharmacol 533 1-3 (2006) 77-88
25. Forsythe P., McGarvey L.P., Heaney L.G., MacMahon J., and Ennis M. Adenosine induces histamine release from human bronchoalveolar lavage mast cells. Clin Sci (Lond) 96 4 (1999) 349-355
26. Weston M.C., and Peachell P.T. Regulation of human mast cell and basophil function by cAMP. Gen Pharmacol 31 5 (1998) 715-719
27. Jenne J.W. Theophylline as a bronchodilator in COPD and its combination with inhaled beta-adrenergic drugs. Chest 92 1 Suppl (1987) 7S-14S
28. Venkayya R., Lam M., Willkom M., Grunig G., Corry D.B., and Erle D.J. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol 26 2 (2002) 202-208
29. Yanagida M., Fukamachi H., Ohgami K., Kuwaki T., Ishii H., Uzumaki H., et al. Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 86 10 (1995) 3705-3714
30. Ma B., Blackburn M.R., Lee C.G., Homer R.J., Liu W., Flavell R.A., et al. Adenosine metabolism and murine strain-specific IL-4-induced inflammation, emphysema, and fibrosis. J Clin Invest 116 5 (2006) 1274-1283
31. Blackburn M.R., Lee C.G., Young H.W., Zhu Z., Chunn J.L., Kang M.J., et al. Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. J Clin Invest 112 3 (2003) 332-344
32. Baggiolini M. Chemokines and leukocyte traffic. Nature 392 6676 (1998) 565-568
33. 2B adenosine receptor subtypes. Biochem Pharmacol 55 5 (1998) 627-633
34. Seitz M., Loetscher P., Dewald B., Towbin H., and Baggiolini M. Opposite effects of interleukin-13 and interleukin-12 on the release of inflammatory cytokines, cytokine inhibitors and prostaglandin E from synovial fibroblasts and blood mononuclear cells. Eur J Immunol 26 9 (1996) 2198-2202
35. Raingeaud J., and Pierre J. Interleukin-4 downregulates TNFalpha-induced IL-8 production in keratinocytes. FEBS Lett 579 18 (2005) 3953-3959
36. Lugering N., Kucharzik T., Kraft M., Winde G., Sorg C., Stoll R., et al. Interleukin (IL)-13 and IL-4 are potent inhibitors of IL-8 secretion by human intestinal epithelial cells. Dig Dis Sci 44 3 (1999) 649-655